Julian Adams to Address Key Cancer Workshop by National Academies
The fight against cancer is set to be invigorated by groundbreaking discussions at an upcoming workshop hosted by the National Academies of Sciences, Engineering, and Medicine (NASEM). Julian Adams, Ph.D., President and CEO of Stand Up To Cancer (SU2C), will be among the prominent speakers. Scheduled for May 20-21, 2025, this pivotal event will unfold in Washington, D.C., with the theme "Cancer Engineering: The Convergence of Engineering and Health to Advance Cancer Research and Care."
Adams will deliver a keynote address during one of the workshop's key sessions, where he is expected to explore the crucial role philanthropy plays in fostering innovation at the intersection of engineering and oncology. This workshop brings together experts from diverse fields to analyze how new engineering advancements and collaborative scientific disciplines can reshape the landscape of cancer research, early detection, and treatment.
Highlighting SU2C's role in championing interdisciplinary cancer research, Adams will emphasize the necessity of collaboration among various sectors to boost the pace at which cancer discoveries are made and implemented in real-world medical practices. Adams remarked, "I’m honored to join this important conversation at the National Academies. Innovation in cancer research increasingly happens at the intersection of biology, data science, engineering, and patient advocacy. Breakthroughs are being driven not only in the lab but also through advances in technology, from imaging and wearable diagnostics to precision tools that improve how we detect, monitor, and treat cancer."
Adams' participation in the workshop underscores SU2C's dedication to translating innovative research findings into effective clinical solutions for cancer patients. As funding across various channels becomes more critical, philanthropic investments are increasingly vital in catalyzing breakthroughs that will ultimately enhance patient outcomes. SU2C recognizes this urgent need and is actively seeking to bridge funding gaps that could otherwise impede progress.
SU2C has long promoted collaborative research through its signature initiatives: the SU2C Convergence program and SU2C Catalyst initiative. These initiatives merge expertise from engineers, physical scientists, and cancer biologists to fuel innovative approaches that lead to significant advances in treatment. Engaging in partnerships across the industry helps SU2C improve the efficacy of their research and widen accessibility to groundbreaking solutions, making significant steps toward equitable cancer care.
The involvement of patient advocacy throughout every research phase ensures that studies remain relevant and impactful for real-world outcomes. As conversations about cancer research continue to evolve, the National Academies workshop represents an opportunity to reassess methodologies and share insights that can push the boundaries of what is possible in cancer treatment and care.
About Stand Up To Cancer: Founded in 2008, Stand Up To Cancer (SU2C) is a nonprofit organization that unites the entertainment industry, scientists, and the public to fund innovative cancer research aimed at delivering new therapies to patients swiftly. To date, more than 3,100 scientists from over 210 institutions have contributed to SU2C-funded projects, advancing the fight against cancer through collaborative efforts.
With a robust scientific partnership with the American Association for Cancer Research (AACR), SU2C employs a rigorous review process to select the most promising research proposals for funding. The organization’s commitment to redefining cancer research models positions it as a leading force in the realm of oncology, pushing forward not only innovation but also hope for countless patients battling this disease.
For more information about SU2C and its initiatives, individuals can visit StandUpToCancer.org or follow their social media channels on Instagram, TikTok, X, Facebook, and YouTube.
Adams will deliver a keynote address during one of the workshop's key sessions, where he is expected to explore the crucial role philanthropy plays in fostering innovation at the intersection of engineering and oncology. This workshop brings together experts from diverse fields to analyze how new engineering advancements and collaborative scientific disciplines can reshape the landscape of cancer research, early detection, and treatment.
Highlighting SU2C's role in championing interdisciplinary cancer research, Adams will emphasize the necessity of collaboration among various sectors to boost the pace at which cancer discoveries are made and implemented in real-world medical practices. Adams remarked, "I’m honored to join this important conversation at the National Academies. Innovation in cancer research increasingly happens at the intersection of biology, data science, engineering, and patient advocacy. Breakthroughs are being driven not only in the lab but also through advances in technology, from imaging and wearable diagnostics to precision tools that improve how we detect, monitor, and treat cancer."
Adams' participation in the workshop underscores SU2C's dedication to translating innovative research findings into effective clinical solutions for cancer patients. As funding across various channels becomes more critical, philanthropic investments are increasingly vital in catalyzing breakthroughs that will ultimately enhance patient outcomes. SU2C recognizes this urgent need and is actively seeking to bridge funding gaps that could otherwise impede progress.
SU2C has long promoted collaborative research through its signature initiatives: the SU2C Convergence program and SU2C Catalyst initiative. These initiatives merge expertise from engineers, physical scientists, and cancer biologists to fuel innovative approaches that lead to significant advances in treatment. Engaging in partnerships across the industry helps SU2C improve the efficacy of their research and widen accessibility to groundbreaking solutions, making significant steps toward equitable cancer care.
The involvement of patient advocacy throughout every research phase ensures that studies remain relevant and impactful for real-world outcomes. As conversations about cancer research continue to evolve, the National Academies workshop represents an opportunity to reassess methodologies and share insights that can push the boundaries of what is possible in cancer treatment and care.
About Stand Up To Cancer: Founded in 2008, Stand Up To Cancer (SU2C) is a nonprofit organization that unites the entertainment industry, scientists, and the public to fund innovative cancer research aimed at delivering new therapies to patients swiftly. To date, more than 3,100 scientists from over 210 institutions have contributed to SU2C-funded projects, advancing the fight against cancer through collaborative efforts.
With a robust scientific partnership with the American Association for Cancer Research (AACR), SU2C employs a rigorous review process to select the most promising research proposals for funding. The organization’s commitment to redefining cancer research models positions it as a leading force in the realm of oncology, pushing forward not only innovation but also hope for countless patients battling this disease.
For more information about SU2C and its initiatives, individuals can visit StandUpToCancer.org or follow their social media channels on Instagram, TikTok, X, Facebook, and YouTube.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.